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Background: Foot infections are a major complication of patients with diabetes 
mellitus (DM). The causative microorganisms are usually polymicrobial.The aim of the study 
is to determine the percentage of microorganism in diabetic foot infection, its susceptibility to 
antibiotic, association between polymicrobial infection and severity of diabetic foot infection 
and to determine the outcome of diabetic foot infection among patients infected with 
polymicrobial organisms in Hospital USM. 
 
Materials and methods: This is a retrospective analysis conducted for one year 
duration starting from June 2014. A total of 104 patients selected from this study. Their 
folders were reviewed and assessed for severity and outcome of foot infection in association 
with polymicrobial infections. Parameters such as glycated haemoglobin (HbA1c), random 
blood sugar (RBS), total white cell (TWC) and haemoglobin (Hb) were analysed. The result 
were presented as descriptive and statistically analysed by Fisher exact test. 
Results: There were 104 patients involved in this study, with a total 133 
microorganisms were isolated with an average of 1.28 organisms per lesion. Gram negative 
(GN) and Gram positive (GP) microorganisms were 62% and 38% respectively.The most 
frequently isolated GN microorganism includes Pseudomonas spp (28%), Proteus spp (11%), 
Klebsiella spp (8%) and E. coli (4%). Staphylococcus aureus was the predominant (54%) 
among GP microorganisms followed by Group B Streptococci (26%) and Enterococcus spp 
(6%). GN isolates were sensitive to carbapenem and aminoglycoside groups while 
vancomycin showed good activity to GP microorganism. There was significant association 
between quantity of microorganisms and severity of diabetic foot infection using Fisher’s 
Exact test (p=0.003). Thirty patients had polymicrobial infections. In severe diabetic foot 
infection, 77.8% with polymicrobial organisms undergone amputation, meanwhile 
monomicrobial infection was 33.3%. Majority of polymicrobial or monomicrobial infection 
was discharged well, 84.0% and 91.1% respectively.  There was no significant association 
between polymicrobial or monomicrobial infection with patient’s outcome of severe diabetic 
foot infection including amputation and discharge of patient (p=0.136 and p=0.465). The 
mean (SD) for HbA1c, RBS, TWC and Hb in severe polymicrobial infections were 11.8(2.1) 
%, 16.3 (5.2) mmol/L, 16.6 (2.4) x 109 and 9.0 (1.3) g/dL respectively. 
 
Conclusion: GN microorganisms were predominantly isolated from diabetic foot 
infections and antibiogram showed that the common organisms remain sensitive to a number 
of widely used agents. Polymicrobial infections were associated with the severity of its 
infection meanwhile quantities of organisms was not associated with patient’s outcome of 
diabetic foot infection. There were higher glucose level and TWC count with lower Hb in 
severe polymicrobial diabetic foot infection. 
 
Professor Madya Dr Siti Asma’ binti Hassan : Supervisor 
Dr Nurahan binti Maning : Co-Supervisor 
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Faktor-faktor Berkaitan Di antara Infeksi Polimikrobial dan Keseriusan 
Jangkitn Kaki Diabetes dalam kalangan Pesakit di Hospital Universiti Sains 
Malaysia 
 
ABSTRAK 
 
Latarbelakang: Jangkitan pada kaki adalah antara komplikasi utama yang di 
alami oleh pesakit diabetes mellitus. Mikroorganisma penyebab biasanya adalah 
polimikrobial. Tujuan kajian ini dilaksanakan adalah untuk mengenalpasti peratus 
mikroorganisma dalam jangkitan kaki pada pesakit diabetes, berserta sensitiviti 
antibiotik terhadap mikroorganisma, hubungkait di antara polimikrobial dan 
keseriusan jangkitan kaki diabetes dan juga untuk mengenalpasti kesudahan 
jangkitan kaki diabetes dalam kalangan pesakit yang dijangkiti oleh polimikrobial 
mikroorganisma di Hospital USM.  
 
Metodologi dan bahan kajian: Ini adalah kajian analisis retrospektif di mana 
ianya dijalankan dalam tempoh setahun bermula daripada Jun 2014 sehingga Jun 
2015. Sejumlah 104 pesakit yang memenuhi kriteria-kriteria yang diperlukan telah 
direkrutkan. Fail pesakit yang mengalami jangkitan kaki diabetes dirujuk bagi kes-
kes yang mempunyai jangkitan monomikrobial atau polimikrobial, penilaian tahap 
keseriusan dan kesudahan infeksi kaki mereka direkodkan. Parameter seperti 
kawalan gula dalam darah, bilangan sel darah putih dan hemoglobin dianalisa. 
Keputusan analisis ini disampaikan dalam bentuk diskriptif dan secara statistik 
menggunakan ujian “Fisher exact”.  
 
 x 
 
Keputusan: Seramai 104 pesakit telah menyertai kajian ini. Sebanyak 133 
mikroorganisma dikenalpasti dengan purata 1.28 mikroorganisma pada setiap 
jangkitan. Gram negatif (GN) menyumbang sebanyak 62% manakala Gram positif 
(GP) sebanyak 38%. Peratus mikroorganisma GN yang paling kerap didapati adalah 
Pseudomonas spp (28%), Proteus spp (11%), Klebsiella spp (8%) dan E. coli (4%). 
Staphylococcus aureusmendominasi (54%) di kalangan GP diikuti oleh Group B 
Streptococci (26%) and Enterococcus spp (6%). Bakteria GN adalah sensitif kepada 
antibiotik dari kumpulan carbapenem dan aminoglycoside manakala bakteria GP 
sensitif kepada vancomycin. Ujian “Fisher’s exact” menunjukkan perkaitan yang 
signifikan antara kuantiti mikroorganisma dan keterukan jangkitan kaki diabetes 
(p=0.003). Tiga puluh pesakit dijangkiti oleh polimikrobial. Di kalangan jangkitan 
kaki diabetes yang serius, 77.8% dijangkiti polimikrobial mengalami amputasi, 
manakala yang dijangkiti monomikrobial adalah 33.3%. Majoriti pesakit daripada 
jangkitan polimikrobial atau monomikrobial didiscaj dengan baik, masing-masing 
pada kadar 84.0% and 91.1%. Kaitan antara jangkitan polimikrobial atau 
monomikrobial dengan kesudahan pesakit jangkitan kaki diabetes yang serius dikaji 
iaitu amputasi dan discaj pesakit, di mana keputusan adalah tidak signifikan (p=0.136 
dan p=0.465). Purata (SD) untuk kawalan gula jangkamasa panjang (HbA1c), 
kawalan gula secara rawak (RBS), bilangan sel darah putih (TWC) dan hemoglobin 
(Hb) dalam jangkitan polimikrobial yang serius adalah masing-masing pada kadar 
11.8(2.1) %, 16.3 (5.2) mmol/L, 16.6 (2.4) x 10 9 dan 9.0 (1.3) g/dL . 
 
Kesimpulan: Isolasi dominan daripada jangkitan kaki diabetes adalah GN dan 
antibiogram menunjukkan mikroorganisma yang biasa dijangkiti masih sensitif 
terhadap kebanyakan antibiotik yang digunakan. Jangkitan polimikrobial adalah 
 xi 
 
berkaitan dengan keseriusan jangkitan manakala tiada kaitan di antara kuantiti 
mikroorgnisma dengan kesudahan jangkitan kaki diabetes. Aras glukos dalam darah 
dan bilangan sel darah putih didapati tinggi dan aras hemoglobin didapati rendah 
dalam jangkitan polimikrobial yang serius.  
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Association between Polymicrobial Infections and Severity of Diabetic Foot 
Infection among Patients in Hospital Universiti Sains Malaysia 
 
ABSTRACT 
 
Background: Foot infections are a major complication of patients with 
diabetes mellitus (DM). The causative microorganisms are usually 
polymicrobial.The aim of the study is to determine the percentage of microorganism 
in diabetic foot infection, its susceptibility to antibiotic, association between 
polymicrobial infection and severity of diabetic foot infection and to determine the 
outcome of diabetic foot infection among patients infected with polymicrobial 
organisms in Hospital USM. 
 
Materials and methods: This is a retrospective analysis conducted for one 
year duration starting from June 2014. A total of 104 patients selected from this 
study. Their folders were reviewed and assessed for severity and outcome of foot 
infection in association with polymicrobial infections. Parameters such as glycated 
haemoglobin (HbA1c), random blood sugar (RBS), total white cell (TWC) and 
haemoglobin (Hb) were analysed. The result were presented as descriptive and 
statistically analysed by Fisher exact test. 
 
Results: There were 104 patients involved in this study, with a total 133 
microorganisms were isolated with an average of 1.28 organisms per lesion. Gram 
negative (GN) and Gram positive (GP) microorganisms were 62% and 38% 
 xiii 
 
respectively.The most frequently isolated GN microorganism includes Pseudomonas 
spp (28%), Proteus spp (11%), Klebsiella spp (8%) and E. coli (4%). Staphylococcus 
aureus was the predominant (54%) among GP microorganisms followed by Group B 
Streptococci (26%) and Enterococcus spp (6%). GN isolates were sensitive to 
carbapenem and aminoglycoside groups while vancomycin showed good activity to 
GP microorganism. There was significant association between quantity of 
microorganisms and severity of diabetic foot infection using Fisher’s Exact test 
(p=0.003). Thirty patients had polymicrobial infections. In severe diabetic foot 
infection, 77.8% with polymicrobial organisms undergone amputation, meanwhile 
monomicrobial infection was 33.3%. Majority of polymicrobial or monomicrobial 
infection was discharged well, 84.0% and 91.1% respectively.  There was no 
significant association between polymicrobial or monomicrobial infection with 
patient’s outcome of severe diabetic foot infection including amputation and 
discharge of patient (p=0.136 and p=0.465). The mean (SD) for HbA1c, RBS, TWC 
and Hb in severe polymicrobial infections were 11.8(2.1) %, 16.3 (5.2) mmol/L, 16.6 
(2.4) x 109 and 9.0 (1.3) g/dL respectively. 
 
Conclusion: GN microorganisms were predominantly isolated from diabetic 
foot infections and antibiogram showed that the common organisms remain sensitive 
to a number of widely used agents. Polymicrobial infections were associated with the 
severity of its infection meanwhile quantities of organisms was not associated with 
patient’s outcome of diabetic foot infection. There were higher glucose level and 
TWC count with lower Hb in severe polymicrobial diabetic foot infection. 
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CHAPTER 1 
INTRODUCTION 
 
1.1  Overview 
As the incidence of diabetes mellitus (DM) is increasing globally, 
complications related to this endocrine disorder are also mounting. Foot infections 
are one of the common complications and are associated with high morbidity as well 
as risk of lower extremity amputation. Severe, chronic, or previously treated 
infections are often infected by polymicrobial infections. The diagnosis and severity 
of diabetic foot infection is based on the clinical signs and symptoms of local 
inflammation. Infected wounds should be cultured after debridement. Tissue 
specimens obtained by scraping the base of the ulcer with a scalpel or by wound or 
bone biopsy are strongly preferred to wound swabs. Imaging studies are indicated for 
suspected deep soft tissue purulent collections or osteomyelitis. Optimal 
management requires aggressive surgical debridement and wound management, 
effective antibiotic therapy, and correction of metabolic abnormalities (mainly 
hyperglycemia and arterial insufficiency). Treatment with antibiotics is not required 
for non infected ulcers. Mild soft tissue infection can be treated effectively with oral 
antibiotics. Severe soft tissue infection can be initially treated intravenously. Direct 
action of antibiotic towards targeted microorganism is better in treating diabetic foot 
infection. 
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1.2  Complications 
Foot ulcers and their complications are an important cause of morbidity and 
mortality in patients with DM. Annual incidence of foot ulcers is 1%to 4% and 
prevalence is 5% to 10% in patients with diabetes (Control et al., 2011). About 50% 
of patients undergoing non traumatic lower limb amputations have DM. These 
patients have a high mortality following amputation, ranging from 39% to 80% at 5 
years (Hunt, 2009). Foot problems in DM continue to challenge the clinicianswho 
care for these patients. Not only are they associated with morbidity and disability, but 
they also lead to significant impairment of quality of life. Although a high mortality 
is well documented in patients with diabetic foot problems following amputation, 
there were long-term mortality in patients with new-onset diabetic foot ulcers 
(Moulik et al., 2003). 
 
Foot ulcers affect one in ten patients with DM during their lifetime(Lipsky et 
al., 2012). They have increased risk of lower-extremity amputations and the main 
cause is diabetic peripheral arterial disease accelerated by the direct damage to the 
nerves and blood vessels by high blood glucose levels. The aim of primary 
amputation is to relieve pain and achieve rapid and successful mobility with an 
artificial limb. Peripheral arterial disease is an independent baseline predictor of the 
non-healing foot ulcer and along with progressing infection continues to be the main 
reason for lower extremity amputation. Although the intact foot may withstand 
markedly reduced skin perfusion, an ulcerated lesion requires a greatly enhanced 
blood flow to heal; therefore, many ulcers fail to heal where critical ischaemia exists. 
The progressive development of an abscess in the presence of ischaemia is an 
 3 
 
ominous sign as it leads to irreparable tissue damage and amputation (Weledji and 
Fokam, 2014). 
 
The 5-year mortality in patients with DM and critical limb ischaemia is 30% 
and about 50% of patients with diabetic foot infections who have foot amputations 
die within five years (Hunt, 2009). The mortality rate is similar to some of the most 
deadly cancers. Poor treatment can lead to lower extremity amputations. About half 
of these amputations can be prevented by proper care. It is vital that the diabetic 
condition in patients with infection is urgently controlled, otherwise the vicious cycle 
of infection leading to the instability of the diabetes and ketosis allows the spread of 
infection. Patients with a severe infection should be hospitalized immediately as 
these are often imminently limb-threatening and, in some cases life threatening 
(Weledji and Fokam, 2014). 
 
Many DFI require surgical procedures, ranging from minor procedure which 
include drainage and excision of infected and necrotic tissues to major procedure, for 
instances, reconstruction of soft tissue or bony defects, revascularization of the lower 
extremity, and lower limb amputation (Lipsky et al., 2012). Smokers, older patients 
with longer history of uncontrolled diabetes, and those with gangrenous infections 
and large ulcers have poorer outcome with amputations (Weledji and Fokam, 2014). 
 
 
 
 4 
 
1.3  Burden 
Medical expenses for people with DM are more than two times higher than 
for people without DM (Control et al., 2011). Among United State residents aged 65 
years and older, 10.9 million or 26.9%, had DM in 2010.About 1.9 million people 
aged 20 years or older were newly diagnosed with DM in 2010 in the United States. 
In 2005–2008, based on fasting glucose or HbA1c levels, 35% of United States 
adults aged 20 years or older had prediabetes while 50% of adults aged 65 years or 
older. Applying this percentage to the entire United States population in 2010 yields 
an estimated 79 million American adults aged 20 years or older with prediabetes. 
DM is the leading cause of kidney failure, non traumatic lower limb amputations, 
and new cases of blindness among adults in the United States (Control et al., 2011). 
 
The prevalence of DM in the Asia region is also clearly increasing, and so is 
the burden of this chronic disease and its complications. In Philippines, a true 
prevalence of about 7.2% among adults aged 20 years and older in 2008. On the 
other hand International Diabetes Federation Diabetes Atlas reports in 2010, 
Indonesia, Malaysia and Singapore prevalence rates of DM were 4.6%, 10.9% and 
12.7%, respectively. These rates are consistent with global estimates, and considering 
the increasing populations in these countries, the absolute numbers are certainly 
staggering (Paz-Pacheco, 2014). 
 
The Malaysian National Health and Morbidity Survey which monitors non 
communicable disease in Malaysian population was increasing in trend, they 
reported the prevalence of DM Type 2 increased from 11.6% in 2006, to 15.2% in 
2011, which equates to approximately 2.6 million adults. This is parallel to three-fold 
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rise in the prevalence of obesity, from 4.4% in 1996 to 15.1% in 2011 for adult age 
18 years and above in which equates to approximately 2.5 million Malaysians who in 
2011 met the criteria for obesity (Mustapha et al., 2014). 
 
1.4  Significance of Study 
In current practice, usually little attention is paid to the possible pathogen that 
causing the diabetic foot infection although some pathogens have different kind of 
virulence as well as response to different antibiotics. Polymicrobial infection of 
diabetic foot infection also contribute in severity of the disease therefore it can be 
one of prognostic factor and more vigilance management should be taken. In order to 
get true pathogen, a proper technique and correct site of sample is acquired.  
 
Thus, by conducting this study, I hope that it will help clinician to improve 
patient’s care of diabetic foot infection. This study can be considered to be included 
as one of the references in the national guidelines on management of diabetic foot 
infection. Since there is no local data available on common pathogens causing 
diabetic foot infection in Malaysia, I also hope that the result of this study can be 
used for proper selection of antibiotics in patients with DFI. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1  Epidemiology of Diabetes Mellitus 
The total number of people who have DM is projected to rise from 171 
million in 2000 to 366 million in 2030. The most important contributor to the rise in 
DM prevalence globally appears to be the increase in the proportion of old people. 
However, given the increasing prevalence of obesity, these figures probably 
underestimate the future diabetes prevalence (Wild et al., 2004). Asia has emerged as 
the ‘diabetes epicenter’ in the world, due to sudden economic development, 
urbanization and nutrition transition over a relatively short period of time. Among 
the 10 countries with the largest numbers of people predicted to have DM in 2030, 
five are in Asia including China, India, Pakistan, Indonesia and Bangladesh (Chen et 
al., 2012) . 
 
2.1.1 Global View 
The number of people with DM is increasing due to population growth, 
aging, urbanization, and increasing prevalence of obesity and physical inactivity. 
Studies done for current and future estimation for DM prevalence and they are 
showed tremendously increasing in trend (King and Rewers, 1993; Wild et al., 2004; 
Guariguata et al., 2014). CDC reported, among U.S. residents aged 65 years and 
older 26.9%, had DM in 2010. About 215,000 people younger than 20 years had DM 
(type 1 or type 2) in the United States in 2010. About 1.9 million people aged 20 
 7 
 
years or older were newly diagnosed with DM in 2010 in the United States (Control 
et al., 2011). 
 
2.1.2 Asian View 
The Asia pacific region with an estimated DM-affected population of 135.4 
million in 2010 is at the forefront of the current epidemic. The rise in prevalence is 
more in developing countries with an estimated projection, of 170% compared to 
42% indeveloped countries to the year 2025. In Malaysia, the prevalence of DM has 
significantly increased from 0.6% in 1960 to 2.1% in 1982, 6.3% in 1986, 8.3 in 
1996 and 14% in 1998 (Zaini, 2000). One of the factors including a rapidly 
developing economy, comprising a multi ethnic population possesses the entire 
favorable environment to support DM progression and its complications (Mafauzy et 
al., 2011). It was reported, people with DM in Malaysia have almost doubled in a 
span of 20 years from 6.3% in 1986 to 11.6% in 2010 (Mafauzy et al., 2011) 
 
Zooming in to Kelantan state, the similar patterns were noted, a 
predominantly Malay village in the north-eastern state of the Peninsula. One study in 
2000 reported which involved a total of 2508 subjects, aged 30 years and above, only 
29.7% were in the urban areas. However, with the overall prevalence of DM at 
10.5% and impaired glucose tolerance (IGT) at 16.5%, the urban–rural gap is getting 
narrower. There were several factors that responsible for the changes of the situation. 
Lifestyle, dietary and body mass changes are apparent and seemed to collaborate 
well with international experiences. Other than these factors the prevalence of 
concomitant hypertension and hyperlipidaemia were alarmingly high and should be a 
cause for concern. A total of 71.9% of the patient with DM subjects,63.0% of the 
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IGT and 57% in the normal group had hypercholesterolaemia. Meanwhile 
hypertension was noted in 12.9% of those with DM, 9% with IGT and 5.3% of the 
normal group (Zaini, 2000). 
 
2.2  Diabetic Foot Infection (DFI) 
DM is a chronic illness requiring continual health care and patient self-
management, education to prevent the development of acute complications and 
reduce the risk of long term complications. As the prevalence of diabetes increases, 
the prevalence of long-term diabetes-related complications is also likely to increase. 
The rates of diabetic complications were cataract 27.2%, microalbuminuria 7%, 
neuropathy symptoms 45.9%, leg amputation 3.8% and history of angina pectoris 
was 18.4%. Quality of life evaluation showed that about one third of patients have 
poor quality of life. The ‘diabetic foot’ has been considered the “Cinderella” 
complication of diabetes care, and the International Diabetes Federation dedicated 
the year 2005 to foot care of people with diabetes in order to raise awareness of foot 
disease among people with diabetes (Boulton et al., 2005). Diabetes-related foot 
ulcers represent challenges for the individual and for the health care system, as they 
increase the demand for specialized health care (Ortegon et al., 2004).  
 
Several predisposing factors for diabetic patients to develop a diabetic foot 
infection, including neuropathy, vasculopathy and immunopathy. The prominent risk 
factor for diabetic foot ulcer that occurs in early pathogenesis of DFI complication is 
peripheral neuropathy. Therefore DM patients with impaired protective sensation and 
altered pain response are vulnerable to trauma and extrinsic forces from ill-fitting 
shoewear. While the motor neuropathy causes muscle weakness and intrinsic muscle 
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imbalance leading to digital deformities such as hammered or clawed toes. This 
condition results in elevated plantar pressure due to metatarsophalangeal joint 
instability. On the other hand, autonomic dysfunction leads to altered in 
microvascular blood flow and arteriolar-venous shunting, diminishing the 
effectiveness of perfusion and elevating skin temperatures. Subsequently, the 
diabetic foot becomes dry and keratinized which cracks and fissures more easily, 
leading to a portal for infection due to loss of sweat and oil gland function (Hobizal 
and Wukich, 2012). 
 
Apart from the obvious clinical predisposing risk factors, a few studies have 
revealed that very complex mechanisms are involved at the tissue-molecular level, 
which prevent normal healing processes (Lobmann et al., 2002; Bennett et al., 2003). 
There are several chemo-cytokines are involved, including matrix 
metalloproteinases, serine proteinases, integrins, chemokines, replicative cell 
senescence, growth factors and adult stem cells. Tissue injury in diabetic patients 
initially show impairment in the immune system response with reduced chemotactic 
effects to recruit inflammatory cells into the damaged tissues, thus, slowing down 
healing and increasing the risk of bacterial infection. After this initial step, when the 
inflammatory response is eventually established, the process switches to an 
exacerbation of proteolysis and inflammation. Glycation of proteins and disturbances 
of cell responses is also generated as the result of prolonged exposure to 
hyperglycemia, thus, further hindering the process of fibrosis and tissue repair. 
Recent molecular studies on chronic diabetic ulcers indicated that more specific 
processes may be involved. For instance, in the ulcer, it has been found that 
leucocytes are prevented from ready entry and accumulation, which, later, fail to 
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achieve normal healing (Leung, 2007). Other studies on the specific properties of 
fibroblasts from patients with chronic diabetic ulcers showed that these cells were 
different from those taken from patients without chronic ulcers in that the high 
molecular weight hyaluronic acid in the pericellular matrix was much more 
concentrated. The unique property of the fibroblasts might predispose these patients 
to chronic ulcer formation (Harding et al., 2002; Yevdokimova, 2003; Yevdokimova 
and Podpryatov, 2005). 
 
DM patients are commonly exposed to the infections and they are often more 
severe than infections found in non diabetic patients. Persons with DM have an 
increased risk for developing an infection of any kind and a several-fold risk for 
developing osteomyelitis (Shah and Hux, 2003). With an incidence of 36.5 per 
1,000persons per year, foot infections are among the most common lower extremity 
complications in the diabetic population (excluding neuropathy), second only to foot 
ulcers infrequency (Lavery et al., 2003). It is well documented that diabetic foot 
infections are frequently polymicrobial in nature (Armstrong and Lipsky, 2004; 
Peters et al., 2012; Lipsky et al., 2014). Hyperglycemia, impaired immunologic 
responses, neuropathy, and peripheral arterial disease are the major predisposing 
factors leading to limb-threatening diabetic foot infections (Lipsky et al., 2004a). 
Uncontrolled DM results in impaired ability of host leukocytes to fight bacterial 
pathogens, and ischemia also affects the ability to fight infections because delivery of 
antibiotics to the site of infection is impaired. Consequently, infection can develop, 
spread rapidly, and produce significant and irreversible tissue damage. Even in the 
presence of adequate arterial perfusion, underlying peripheral sensory neuropathy 
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will often allow the progression of infection through continued walking or delay in 
recognition. 
 
Foot infections in persons with DM are often initially treated empirically. The 
empirical antibiotics using are usually mend for broad spectrums organisms’ 
coverage or according to local antibiogram study. Hence, therapy directed at known 
causative organisms may improve the outcome. Many studies have reported on the 
bacteriology of DFIs over the past 25 years, but the results have varied and have 
often been contradictory (Citron et al., 2007). Therefore study on local causative 
organism and antibiogram of DFI is an essential tool for better management of 
diabetic foot patients. A number of studies have found that Staphylococcus aureus is 
the main causative pathogen (Lipsky et al., 2004b; Raja, 2007; Eleftheriadou et al., 
2010), but more recent investigations reported a predominance of Gram-negative (Al 
Benwan et al., 2012; Hefni et al., 2013). The role of anaerobes is particularly 
unclear, because in many studies specimens were not collected or cultured properly 
to recover these organisms. Among those that did use appropriate methods, some 
report that anaerobes play a minimal role and Bacteroides fragilis is the predominant 
anaerobe isolated (Díaz et al., 1992; Senneville et al., 2006). 
 
These discrepancies of aetiological agents could be partly due to differences 
in the causative organisms occurring over time, geographical variations, or the types 
and severity of infection included in the studies. In addition, some studies used a 
relatively small number of specimens, failed to report recent or concomitant 
antibiotic therapy, did not ensure that the specimen collection techniques would 
exclude superficial or colonizing organisms, or even make clear whether or not the 
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wound was clinically infected. Also, laboratory processing of the samples may have 
been inadequate to grow anaerobes or fastidious organisms, and protocols that 
classify potential pathogens for examples coagulase-negative staphylococci or 
Corynebacterium spp as colonizers may have been used (Lipsky et al., 2012). 
 
S. aureus and beta-hemolytic streptococci are widely recognized as pathogens 
in early DFIs, the role of other frequently isolated organisms is less clear to both the 
clinician and the microbiology laboratory. Previous studies have shown that when 
optimal specimen collection, transport, and culture techniques are used, multiple 
organisms are usually recovered from DFIs (Lipsky et al., 2004a; Lipsky et al., 
2014). Furthermore, some studies suggest that the interactions of organisms within 
these polymicrobial mixtures lead to the production of virulence factors, such as 
hemolysins, proteases, and collagenases, as well as short-chain fatty acids, that cause 
inflammation, impede wound healing, and contribute to the chronicity of the 
infection. In such mixtures, biofilms that impede the penetration of antimicrobial 
agents into the infected site may also form (Peters et al., 2012). Thus, the presence of 
multiple species can have important clinical implications that should not be 
overlooked. 
 
Figure 2.2.1 Diabetic foot infection[Adopted from (Frykberg et al., 2006)] 
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2.3  Risk for Infection 
DM patients are commonly exposed to the infections and they are often more 
severe than infections found in non diabetic patients. Persons with DM have an 
increased risk for developing an infection of any kind and a several-fold risk for 
developing osteomyelitis (Shah and Hux, 2003). With an incidence of 36.5 per 
1,000persons per year, foot infections are among the most common lower extremity 
complications in the diabetic population (excluding neuropathy), second only to foot 
ulcers infrequency (Lavery et al., 2003). It is well documented that DFIs are 
frequently polymicrobial in nature (Armstrong and Lipsky, 2004; Peters et al., 2012; 
Lipsky et al., 2014). 
 
Hyperglycemia, impaired immunologic responses, neuropathy, and peripheral 
arterial disease are the major predisposing factors leading to limb-threatening DFI 
(Lipsky et al., 2004a). Uncontrolled DM results in impaired ability of host 
leukocytes to fight bacterial pathogens, and ischemia also affects the ability to fight 
infections because delivery of antibiotics to the site of infection is impaired. 
Consequently, infection can develop, spread rapidly, and produce significant and 
irreversible tissue damage. Even in the presence of adequate arterial perfusion, 
underlying peripheral sensory neuropathy will often allow the progression of 
infection through continued walking or delay in recognition. 
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2.4  Microbiology of Diabetic Foot Infection 
2.4.1 Quantity of Microorganism in Diabetic Foot Infection 
Microbes rarely exist as single-species planktonic forms. The majority are 
found thriving in complex polymicrobial biofilm communities attached to biotic and 
abiotic sites. Polymicrobial biofilm communities may be defined as a varied 
collection of organisms (fungi, bacteria, and viruses) that exist at a phase or density 
interface and are coated in a self- and/or host-derived hydrated matrix, often 
consisting of polysaccharide (Brogden et al., 2005). Some microbes have evolved 
mutualistic or even synergistic relationships to facilitate cohabitation on epithelial 
surfaces and to efficiently utilize metabolic by-products, while others have developed 
competitive antagonistic approaches during colonization. These relationships are 
manifested by contact-dependent attachment, cell-cell communication via quorum-
sensing cross talk, an enhancement of colonization, augmented virulence phenotypes 
in trans, immunomodulation, or a combination of these events (Peleg et al., 2010). 
 
Observations using the earliest microscopes revealed the colonization of 
multispecies communities on human tissues. However, people still do not have a 
solid understanding of how multi species interactions govern the scope, progression, 
and severity of human disease, and even less is known regarding how the host 
responds to polymicrobial infection compared to monomicrobial infection (He and 
Shi, 2009). It was previously believed that a single virulence factor sufficiently 
mediated disease caused by a single organism. While this is true for some human 
infections, immunization against single virulence factors of other organisms (i.e., 
Staphylococcus aureus) has proven much more difficult. Just as virulence can no 
longer be associated with a single virulence factor for some organisms, some 
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diseases can no longer be defined as an infection by a single species (Cripps and 
Otczyk, 2006) 
 
Most diseases were previously characterized as being monomicrobial in 
nature, likely due to the extensive use of culture dependent isolation techniques. 
However, with the advent of culture-independent community analysis 
methodologies, several are becoming increasingly recognized as true polymicrobial 
infections, including diseases of the diabetic foot wound infections. In these cases, 
the composition of microbial populations predicts disease severity and outcome. 
Therefore, epidemiologic identification and comprehensive pyrosequencing surveys 
during human infection coupled with mechanistic studies of derived novel 
interspecies cross-kingdom microbial relationships should lead to the increased 
surveillance of potential disease risk factors (Peters et al., 2012). 
 
Another damaging effect of high glucose levels mediated by an insulin 
deficiency or resistance is the development of peripheral neuropathy and poor blood 
circulation, especially in extremities such as the hands and feet. Combined, these 
symptoms predispose diabetic individuals to an increased risk of infection, and if not 
identified or treated early, these infections may fulminate into chronic ulcerating 
polymicrobial biofilm-mediated wounds that often do not resolve with standard 
therapies and result in eventual limb amputation (Wu et al., 2007). The development 
of such ulcers is often the synergy of two contributing factors, e.g., decreased 
neurosensory perception and stepping on a sharp object; it is this critical breach of 
the epithelial surface, coupled with neurological abnormalities, cardiovascular 
aberrations, and immune dysfunction, which facilitates polymicrobial colonization 
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and subsequent pathogenesis. Due to the inability of subjects with this disease to feel 
cuts and irritations on visually obscured areas of the feet, these infections often go 
unnoticed and progress to more serious illness (Boulton, 2010). 
 
DFIs are often mediated by a mixture of several species of microbes 
coexisting as complex biofilm communities. A large multicenter analysis of 454 
individual diabetic foot wound infection swabs and aspirates resulted in the 
identification of over 1,600 organisms by aerobic and anaerobic culturing techniques. 
Interestingly, of the specimens tested, 48.9% were infected with aerobic bacteria 
only, 1.3% was infected with anaerobic bacteria only, and 43.9% contained a mixture 
of aerobic and anaerobic bacteria. Bacterial growth was not identified in 5.9% of the 
samples. Of the positive cultures identified,16.2% harbored one bacterial isolate, 
20.4% contained two bacterial isolates, 19.7% had three bacterial isolates, 13.3% 
demonstrated four bacterial isolates, and 30.4% supported the growth of five or more 
bacterial isolates. Of these, the most abundant aerobic isolates recovered were 
Corynebacterium spp., Enterococcus spp., Escherichia coli, Staphylococcus 
epidermidis, and S. aureus; among the most commonly isolated anaerobic bacteria 
were Fusobacterium spp., Porphyromonas spp., Prevotella spp., Bacteroidesspp., 
and Clostridium spp (Citron et al., 2007).  
 
A smaller-scale study using denaturing gradient gel electrophoresis (DGGE), 
16SrRNA gene sequencing techniques, and microscopy to examine debrided tissues 
from diabetic foot wounds resulted in the identification of highly polymicrobial 
communities and the detection of several species unidentifiable by standard culturing 
techniques (James et al., 2008). Notably, DGGE analysis demonstrated the presence 
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of several unique bands (corresponding to unique species) for each sample tested, 
and banding patterns differed between individual samples. While no distinct 
relationships between coisolated organisms can be derived from these analyses, these 
studies demonstrate the tremendous diversity in microbial composition and the true 
polymicrobial nature of diabetic foot wound diseases. As of now, it is unclear 
whether diabetic foot wounds arise from specific combinations of pathogens or if a 
simple increase in the microbial loads of any opportunistic microbes can sustain 
infection. 
 
2.5  Pathogenesis 
Patients with DM were predisposed with many factors in developing DFI. 
Several factors including neuropathy, vasculopathy and immunopathy are important 
role in contributing this complication. In early pathogenesis, most prominent risk 
factor considered for diabetic foot ulcers is peripheral neuropathy (Reiber et al., 
1999). Patients with DM usually has an impaired protective sensation because 
presence of pain response alteration. Thus they are vulnerable to trauma and extrinsic 
forces from ill-fitting shoewear. On the other hand, motor neuropathy causes intrinsic 
muscle imbalance and muscle weakness leading to digital deformities such as 
hammered or clawed toes. Hence causing metatarsophalangeal joint instability that 
resulted in elevated plantar pressure. Autonomic dysfunction leads to changes in 
microvascular blood flow and arteriolar-venous shunting, diminishing the 
effectiveness of perfusion and elevating skin temperatures. Patients with DM, their 
foot becomes dry and keratinized which can cause cracks and fissures due to loss of 
sweat and oil gland function which can lead to a portal for infection (Snyder et al., 
2010). 
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The next element in pathogenesis of DFI is vasculopathy. Diabetic 
angiopathy is reported to be the most frequent cause of morbidity and mortality in 
patients with DM (Joseph and LeFrock, 1987). Infrapopliteal vessels typically 
involved as diffuse multisegmental in macroangiopathy manifestations and is also 
associated with compromised collateral circulation. This is considered an 
atherosclerotic obstructive disease of large vessels, which leads to peripheral arterial 
disease (PAD) of the lower extremities(Hobizal and Wukich, 2012). The PAD is 
considered an independent associated factor in increase risk in getting DFI (Peters et 
al., 2005). Meanwhile, microangiopathy results in altered nutrient exchange, 
capillary basement membrane thickening, microcirculation ischemia and tissue 
hypoxia that leading to development of DFI (Association, 2014).  
 
Immunopathy has been implicated in the patients with DM inherent 
susceptibility to infection as well as the potential to mount a normal inflammatory 
response. Impaired host defenses secondary to hyperglycemia include defects in 
leukocyte function and morphologic changes to macrophages (Bagdade et al., 1974). 
In pathogenesis of DFI demonstrated that significantly reduction of leukocyte 
phagocytosis in patients with poorly controlled DM, and correction of hyperglycemia 
was directly correlated with improvement of microbiocidal rates. There were reduced 
chemotaxis of growth factors and cytokines, coupled with excess of 
metalloproteinases, delay normal wound healing by creating a prolonged 
inflammatory state leading to development of DFI (Hobizal and Wukich, 2012). 
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Catabolic state is associated with fasting hyperglycemia and the presence of 
an open wound. While gluconeogenesis from protein breakdown causing negative 
nitrogen balance as a result of secondary to insulin deprivation. This metabolic 
dysfunction impairs the synthesis of proteins, fibroblasts and collagen and further 
systemic deficiencies are propagated which lead to nutritional compromise. Research 
indicates impairment of the immune system with serum glucose levels >150 ml/dl 
(Inzucchi, 2006). Patients with DM tolerate infection poorly and infection adversely 
affects diabetic control. Thus, repetitive cycle leads to uncontrolled hyperglycemia, 
further affecting the host’s response to infection (Hobizal and Wukich, 2012). 
 
2.6  Clinical Features and Diagnosis 
All skin wounds contain microorganism, making a diagnosis of infection is 
not an easy procedure. Therefore, infection must be diagnosed clinically, that is, by 
the presence of systemic signs including fever, chills and leukocytosis. Others are 
purulent secretions (pus), or local classical signs or symptoms of inflammation 
including warmth, redness, pain or tenderness, and induration. In chronic wounds, 
additional signs suggesting infection may include delayed healing, abnormal 
coloration, friability, or foul odor (Lipsky et al., 2012). 
 
In the presence at evidence of a systemic infection or of a metabolic disorder 
and at the first appearance of a foot problem, the infection should be suspected. 
However, sometimes the diagnosis of infection can be delayed by peripheral 
neuropathy or ischemia that causing either mask or mimic inflammation (Lipsky, 
2004). Occasionally, inflammatory signs may be caused by other noninfectious 
disorders; on the other hand, some uninflamed ulcers may be associated with 
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underlying osteomyelitis (Newman et al., 1991). In DFI signs of systemic toxicity 
are surprisingly uncommon, even those that are limb threatening.  
 
Proper evaluation of a DFI requires a methodical approach. Whenever 
infection is considered, this diagnosis should be pursued aggressively; these 
infections can worsen quickly, sometimes in a few hours. Almost two-thirds of 
patients with a DFI have evidence of peripheral vascular disease, and about 80% 
have lost protective sensation (Lipsky, 2001). Forefoot is the most part of infections, 
especially the toes and metatarsal heads, particularly on the plantar surface. About 
half of the patients in reported series have received antibiotic therapy for the foot 
lesion by the time they present, and up to one third have had a foot lesion for more 
than one month. Many patients do not report pain, and more than half, including 
those with serious infections, do not have a fever, elevated WBC count, or elevated 
ESR (Lipsky, 2004). 
 
Several classification systems have been proposed for diabetic foot lesions, 
none of which is universally accepted. Keys to classifying a foot wound are assessing 
the depth of the lesion by visually inspecting the tissues involved and by estimating 
the depth in millimeters as well as checking for ischemia by absent pulses or 
diminished blood pressure in the foot. Other key is by looking for infection. Whereas 
mild infections are relatively easily treated, moderately severe infections may be 
limb threatening, and severe infections may be life threatening. Assessing the 
severity of infection is essential to determine the need for hospitalization, selecting 
an antibiotic regimen and influences the route of drug administration. Severity of 
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infection also helps to assess the potential necessity and timing of surgery and the 
likelihood of amputation (Armstrong et al., 1998).  
 
The wound should be carefully explored to seek foreign or necrotic material, 
and it should be probed with a sterile metal instrument. Deep space infections often 
have deceptively few superficial signs. The clinician should suspect spread of 
infection when there is inflammation distant from the skin wound, or when 
suppurative lesions persist despite apparently appropriate therapy. A surgeon should 
evaluate any patient with systemic toxicity for an occult deep space infection. 
Clinical features that help define the severity of infection. 
 
One of the first, and the most financially dominant, decisions when faced 
with a DFI is to determine whether a patient should be hospitalized. Several 
indications for hospitalization, patients with a serious infection and possible surgical 
interventions, fluid resuscitation, and control of metabolic derangements. 
Hospitalization should also be considered if the patient is unable or unwilling to 
perform proper wound care, cannot or will not be able to off-load the affected area, is 
unlikely to comply with antibiotic therapy, requires parenteral antibiotic therapy, or 
needs close monitoring of response to treatment. In the absence of these factors, most 
patients can be treated cautiously on an outpatient basis, with frequent (i.e., every 
few days, initially) reevaluation. Wound care (debridement, dressing changes, and 
pressure off-loading) and glycemic control should be optimized; antibiotics will not 
overcome inattention to these fundamentals (Lipsky, 2008). 
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Table 2.6.1 Clinical manifestation with severity diabetic foot infection [Adopted 
from (Lipsky et al., 2012)] 
 
 
2.7  Treatment 
Several basic factors that should considered in determining an antibiotic 
regimen include clinical severity of infection, etiologic agents either known or 
presumed, bone infection and allergies to antibiotics (Lipsky et al., 2004a).  The 
initial antibiotic regimen must usually be selected empirically, and it may be 
modified later on the basis of availability of additional clinical and microbiological 
information. Choosing an empiric regimen involves making decisions about the 
spectrum of microorganisms to be covered, route of therapy and specific drugs to 
administer.  
 
These decisions should be revisited when deciding on the definitive regimen 
and the appropriate duration of treatment. Initial empiric therapy should be based on 
the severity of the infection and on any available microbiological data, such as recent 
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culture results and the local prevalence of pathogens, especially antibiotic-resistant 
strains (Ramakant et al., 2011). Available data suggest that 40%– 60% of diabetic 
patients who are treated for a foot ulcer receive antibiotic therapy (Jaegeblad et al., 
1999). One study reported a randomized trial in which 64 diabetic patients who 
received antibiotic therapy for clinically uninfected foot ulcers had a significantly 
increased likelihood of healing and had a reduced incidence of clinical infection, 
hospitalization, and amputation (O'meara et al., 2001). Conversely antibiotic therapy 
is associated with frequent adverse effects, substantial financial costs, and the 
development of resistance and, thus, should currently be used only to treat 
established infection (Lipsky et al., 2004a). The majority of mild, and many 
moderate, infections can be treated with agents that have a relatively narrow 
spectrum, usually covering only aerobic Gram positive cocci (Lipsky et al., 1990). In 
countries with warm climates, gram-negative isolates (especially P. aeruginosa) are 
more prevalent. Obligate anaerobic organisms are isolated from many chronic, 
previously treated, or severe infections (Ng et al., 2008).  
 
For severe infections, and for more extensive, chronic moderate infections, it 
is safest to promptly commence therapy with a broad-spectrum regimen. The 
agent(s) should have activity against Gram positive cocci, as well as common Gram 
negative and obligate anaerobic organisms to ensure adequate tissue concentrations. 
For these more severe infections, it is usually safest to start with parenteral therapy, 
which can usually be switched to oral treatment within a few days when the patient is 
systemically well and culture results are available to guide the selection. Clinicians 
should consider the results of culture and sensitivity testing in light of the clinical 
response of the infection to the empiric regimen. Cultures may yield organisms that 
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are commonly considered to be contaminants (eg, coagulase negative staphylococci, 
corynebacteria), but these may be true pathogens in a DFI. Because these organisms 
are often resistant to the prescribed antibiotic, the clinician must decide if the 
preponderance of clinical and microbiologic evidence suggests they are pathogens 
that require targeted therapy. If the patient has had a good clinical response on the 
empiric therapy, the regimen may be continued, or even potentially narrowed 
(“deescalation” therapy) (Lipsky et al., 2012). 
 
The key to successful antibiotic therapy is achieving a therapeutic drug 
concentration at the site of infection. This typically requires first achieving adequate 
serum levels. Intravenous antibiotics are indicated for patients who are systemically 
ill, have a severe infection, are unable to tolerate oral agents, or are known or 
suspected to have pathogens that are not susceptible to available oral agents (Lipsky 
et al., 2004a). The optimal duration of antibiotic therapy for diabetic foot infections 
has not been studied. For mild to moderate infections, a one to two week course has 
been found to be effective (Lipsky et al., 1990), whereas for more serious infections, 
treatment has usually been given for about 2 weeks, sometimes longer. Adequate 
debridement, resection, or amputation of infected tissue can shorten the necessary 
duration of therapy. For those few patients with diabetic foot infection who develop 
bacteremia, therapy for at least 2 weeks seems prudent. Antibiotic therapy can 
generally be discontinued when all signs and symptoms of infection have resolved, 
even if the wound has not completely healed. Healing any skin ulcer is a separate, 
albeit important, issue in treating diabetic foot infections. In some instances of 
extensive infection, large areas of gangrene or necrotic tissue, or poor vascular 
supply, more prolonged therapy may be needed. Some patients who cannot, or will 
